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DISPATCHES
Marjolein Knoester, Elisabeth H. Schölvinck, 
Randy Poelman, Sylvia Smit,  
Clementien L. Vermont, Hubert G.M. Niesters, 
Coretta C. Van Leer-Buter
In June and July 2016, we identified 8 adults and 17 chil-
dren with respiratory enterovirus D68 infections. Thirteen 
children required intensive care unit admission because 
of respiratory insufficiency, and 1 had concomitant acute 
flaccid myelitis. Phylogenetic analysis showed that all of 
20 sequences obtained belong to the recently described 
clade B3.
The largest enterovirus D68 (EV-D68) outbreak oc-curred in the United States during the summer and fall 
of 2014. Approximately 1,100 respiratory EV-D68 infec-
tions were recorded, mostly in children, many of whom re-
quired intensive care unit (ICU) admission. Most diseases 
were of respiratory nature, but concurrent with the upsurge 
of EV-D68, the Centers for Disease Control and Prevention 
(Atlanta, GA, USA) recorded 120 cases of acute flaccid 
myelitis (AFM) (1). A Europewide study identified circu-
lation of EV-D68 during the same period. Although num-
bers were lower, ICU admissions and 3 cases of AFM were 
reported (2). Before 2014, only a few small outbreaks of 
EV-D68 had been described worldwide, all with respira-
tory infections.
Our clinical virology laboratory (University Medical 
Center Groningen, Groningen, the Netherlands) reported 
an increase of EV-D68 infections in 2010 and again in 
2014, in parallel with the US outbreak (3,4). Very limited 
activity of EV-D68 was observed in 2015. Since June 2016, 
we have again identified a substantial increase in respirato-
ry EV-D68 infections in our hospital, just 2 years after the 
previous upsurge. To raise awareness of this upsurge and 
the severity of EV-D68 infections, we report on 25 cases. 
In addition, we show the phylogenetic relationship between 
the 2016 EV-D68 strains and those that circulated in 2014.
The Study
The University Medical Center Groningen is a tertiary re-
ferral center in the northern part of the Netherlands. We 
perform routine diagnostic real-time PCR for all patients 
evaluated for respiratory disease by laboratory developed 
tests for 17 targets, including adenovirus, bocavirus, coro-
navirus, enterovirus, metapneumovirus, influenza, parain-
fluenzavirus, rhinovirus, and respiratory syncytial virus (5). 
From all enterovirus detections with a cycle threshold (Ct) 
value <31, we sequence part of the viral protein 1 gene on a 
weekly basis (6). To obtain rapid typing results in the cur-
rent outbreak, a specific EV-D68 real-time PCR was also 
used (3), when enterovirus PCR was found positive.
We identified 3 EV-D68 infections in June and 22 ad-
ditional cases in July. We found a stable seasonal variance 
for enterovirus and a sudden rise of enterovirus infections 
in July, mainly caused by EV-D68 (Figure 1).
The EV-D68–positive specimens were nasopharyn-
geal swabs (n = 8), sputum (n = 2), and nasopharyngeal 
brushes (n = 15). Two viral respiratory co-infections were 
detected: rhinovirus A15 in patient 12 (enterovirus Ct 17, 
rhinovirus Ct 21) and parainfluenzavirus type 4 in patient 
23 (enterovirus Ct 14, parainfluenza virus 4 Ct 31). For 20 
patients, we obtained sequence results identifying EV-D68; 
the remaining 5 could not be typed by sequencing but were 
positive in our specific EV-D68 PCR.
Of the 25 patients, 8 were adults and 17 were children 
(Table). In the adults, 6 of whom were transplant recipi-
ents, symptoms were mild and influenza-like. In children, 
however, we observed life-threatening respiratory distress, 
for which ICU admission was necessary for 13 (Table). 
Twenty-one patients had an underlying or concurrent con-
dition, in the children mostly pulmonary.
One child (patient 16) had the clinical characteris-
tics of AFM. This nearly 4-year-old boy had a history of 
headaches for 1 week and an influenza-like illness for 3 
days. He had rapidly progressing asymmetric weakness of 
arms and legs, bulbar paralysis, asymmetric facial paraly-
sis, and respiratory distress for which he needed ventila-
tory support. Cerebrospinal fluid (CSF) analysis showed 
no abnormalities. Axial fluid-attenuated inversion recovery 
magnetic resonance imaging (MRI) showed hyperintense 
nonenhancing gray matter lesions in brainstem and spinal 
cord. Electromyography findings supported injury on the 
level of the motor axon or the anterior horn of the spinal 
cord. No varicella zoster virus, herpes simplex virus, en-
terovirus, or parechovirus were detected in the CSF. In the 
nasopharyngeal swab, only EV-D68 was detected.
All patients in this report were treated in our tertiary 
referral hospital, but they originated from different regions 
in the north of the Netherlands. Spatial epidemiology data 
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did not suggest an epidemiologic link or outbreak (data not 
shown). In 2 children, EV-D68 symptoms developed >48 
hours after admission; the source of possible nosocomial 
infection was not identified.
We obtained 20 sequences of part of the EV-D68 vi-
ral protein gene and aligned them with the sequences from 
the 2014 epidemic. Clades were assigned as described 
previously (7) by the neighbor-joining method by using 
BioNumerics software 6.6 (Applied Maths/bioMérieux, 
Sint-Martens-Latem, Belgium). Sequence analysis (Fig-
ure 2) showed that the 2016 strains were closely related 
to sequences of the recently described subclade B3 (8), 
Figure 1. Respiratory enterovirus infections, University Medical Center Groningen, the Netherlands, 2014, 2015, and 2016. The 
total numbers of respiratory specimens tested for enterovirus in these years during April–July were 784, 828, and 871, respectively. 
Seventeen (2.2%) of 784 were positive for enterovirus in 2014, 5 (0.6%) of /828 in 2015, and 33 (3.8%) of /871 in 2016. Six (35%) of 17 




Table. Characteristics of patients with EV-D68 infection, University Medical Center Groningen, Groningen, the Netherlands, June 11– 
August 1, 2016* 
Patient Date† Age/sex Concurrent condition(s) Clinical characteristics 
ICU admission, 
days in ICU 
1 Jun 11 1 y /M None Bronchial obstruction, respiratory failure Yes/4 
2 Jun 20 3 y/M None Status asthmaticus Yes/3 
3 Jun 30 61 y/F Lung and liver transplantation Cough, runny nose No 
4 Jul 4 5 y/M Asthma Status asthmaticus Yes/2 
5 Jul 5 3 y/M Asthma Status asthmaticus Yes/3 
6 Jul 7 67 y/F Autologous stem cell transplantation Influenza-like syndrome, dyspnea No 
7 Jul 7 2 y/M Pulmonary hypertension, 
underdeveloped lung vessels 
Respiratory failure Yes/4 
8 Jul 11 70 y/F Allogenic stem cell transplantation Influenza-like syndrome, dyspnea No 
9 Jul 14 66 y/F Allogenic stem cell transplantation Cough, fever No 
10 Jul 16 3 y/M Asthma Status asthmaticus Yes/4 
11 Jul 16 3 mo/M Bronchopulmonary dysplasia of 
prematurity 
Respiratory failure Yes‡ 
12 Jul 16 1 y/F Bronchial hyperreactivity, failure to thrive Bronchial obstruction, respiratory failure Yes/8 
13 Jul 22 5 y/F Asthma Status asthmaticus Yes/5 
14 Jul 22 1 y/M Tracheal stoma for bilateral vocal cord 
paralysis 
Cough, wheezing No 
15 Jul 23 3 y/M None Status asthmaticus Yes/5 
16 Jul 24 3 y/M Atypical seizures 3 y prior Acute flaccid myelitis Yes/ongoing§ 
17 Jul 25 19 y/F None Influenza-like syndrome No 
18 Jul 25 3 y/M Bronchial hyperreactivity Asthma exacerbation No 
19 Jul 25 5 mo/M 22q11 deletion, tetralogy of Fallot, 
tracheal stoma 
Acute mechanical airway obstruction, 
resuscitation 
No¶ 
20 Jul 28 50 y/M Lung transplantation Cough, runny nose No 
21 Jul 28 3 y/M Spinal muscular atrophy Respiratory failure Yes/5 
22 Jul 29 9 mo/M Corrected esophagal atresia with related 
tracheomalacy for which noninvasive 
ventilation at home 
Respiratory distress with bronchorrhea No 
23 Jul 30 3 y/F Bronchial hyperreactivity Status asthmaticus Yes/2 
24 Jul 30 51 y/F Autologous stem cell transplantation Influenza-like syndrome No 
25 Jul 31 23 y/M Childhood asthma Cough, dyspnea, nausea, vomiting No 
*EV, enterovirus; ICU, intensive care unit. 
†Date of first EV-D68–positive specimen. 
‡Patient 11 contracted EV-D68 in the neonatal ICU. 
§Patient still in ICU as of December 6, 2016.  
¶Patient 19 acquired EV-D68 while admitted to the special care ward since birth. 
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represented in Figure 2 by 4 sequences from China. The 
nucleotide divergence was 2.1% within B3, 5.5% between 
B1 and B3, and 7.3% between B2 and B3. We submitted 
our 20 sequences from 2016 to GenBank (accession nos. 
KX685066–KX685084 and KX710328).
Conclusions
After the upsurge of EV-D68 in our region during 2009 
and 2010, we set up routine genotypic characterization for 
several viral pathogens, including enterovirus and rhinovi-
rus, which is also offered to regional referring hospitals and 
healthcare institutions. Sequencing results are available 
within 1 week, which provides clinically relevant and epi-
demiologic information. This so-called REGIOTYPE strat-
egy contributed to timely detection of EV-D68 in our hos-
pital in 2014, as well as in 2016. We recognized a sudden 
reappearance of EV-D68 with a sharp increase of cases that 
could not be explained by a change in surveillance strategy.
In line with previous outbreaks, mostly children were 
affected, and those with underlying pulmonary conditions 
seemed at higher risk for ICU admission (9). The number 
of children who needed ICU admission was higher in 2016 
than in our 2010 and 2014 reports (3,4). Although dynam-
ics of viral disease and shedding are not known for EV-
D68, we assume a role for EV-D68 in the symptoms of 
patients 12 and 23, as, in line with rhinovirus infections, 
higher viral load might indicate symptomatic disease (10).
Evidence that EV-D68 might cause AFM is increas-
ing after recent epidemiologic investigations (1,11,12). In 
patient 16, atypical Guillain-Barré syndrome initially was 
diagnosed; however, this diagnosis was later discarded be-
cause the electromyography results indicated motoric axon 
or anterior horn cell disease, and the clinical picture and 
MRI results were in favor of AFM (13). MRI findings were 
subtle, and radiologic diagnosis was made only after fur-
ther review and discussion of the case with the neurolo-
gists. The absence of EV-D68 in CSF is consistent with 
previous reports (1,12).
Sequencing results showed that the strains in our study 
cluster in the recently described clade B3 (8). During the 
2014 outbreak, most EV-D68 sequences belonged to clades 
B1 and B2, although A1 and A2 were also represented 
Figure 2. Maximum-parsimony tree of partial viral protein 1 sequences of enterovirus D68 (EV-D68). Included are the strains obtained 
in the laboratory of the University Medical Center Groningen (Groningen, the Netherlands) in 2014 (light gray, n = 23) and 2016 (black, 
n = 20) and worldwide isolates from 2014 (dark gray, n = 73). Recent strains cluster in the recently described clade B3, with a nucleotide 
divergence of 2.1% within clade B3, 5.5% to clade B1, and 7.3% to clade B2. Clades are according to Tokarz et al. and Gong et al (7,8). 
We submitted the 20 sequences we obtained during 2016 to GenBank under accession nos.: KX685066–KX685084 and KX710328. 
CHN, China; DNK, Denmark; ESP, Spain; FIN, Finland; FRA, France; GER, Germany; IRL, Ireland; ITA, Italy; NLD, the Netherlands; 
SVN, Slovenia; USA, United States. White circles indicate reference strains (n = 2).
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(2,14). Larger epidemiologic and genotyping studies are 
needed to evaluate whether the distinction within clade B 
is tenable and whether our clinical findings are typical for 
subclade B3.
This upsurge could indicate an active EV-D68 season, 
as highlighted by the epidemiologic curve, with a potential 
increase in AFM cases. Clinicians should be alert for EV-
D68, its clinical implications, and the need for appropriate 
diagnostics, particularly in children who are admitted with 
respiratory failure to the ICU or with possible symptoms 
of AFM.
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